Payer Almanac
About the data Sign in
Star measuresDisplay measuresHEDISWhy members leave

Measures · D12 in 2021 · Part D · DD4 Drug Safety and Accuracy of Drug Pricing

Medication Adherence for Cholesterol (Statins)

Drug PlanMedication AdherenceSource: Prescription Drug Events

What it measures
Percent of plan members with a prescription for a cholesterol medication (a statin drug) who fill their prescription often enough to cover 80% or more of the time they are supposed to be taking the medication. One of the most important ways people with high cholesterol can manage their health is by taking medication as directed. The plan, the doctor, and the member can work together to do this.
How it's calculated
This measure is defined as the percent of Medicare Part D beneficiaries 18 years and older who adhere to their prescribed drug therapy for statin cholesterol medications. This percentage is calculated as the number of member-years of enrolled beneficiaries 18 years and older with a proportion of days covered (PDC) at 80 percent or higher for statin cholesterol medication(s) during the measurement period (numerator) divided by the number of member-years of enrolled beneficiaries 18 years and older with at least two statin cholesterol medication fills on unique dates of service during the measurement period (denominator). The PDC is the percent of days in the measurement period “covered” by prescription claims for the same medication or another in the therapeutic category. Beneficiaries are only included in the measure calculation if the first fill of their statin medication occurs at least 91 days before the end of the enrollment period. The Medication Adherence measure is adapted from the Medication Adherence- Proportion of Days Covered measure that was developed and endorsed by the Pharmacy Quality Alliance (PQA). See the medication list for this measure. The Medication Adherence rate is calculated using the National Drug Code (NDC) list and obsolete NDC date methodology maintained by the PQA. The complete NDC list is posted along with these technical notes.
Data source
Prescription Drug Event (PDE) data The data for this measure come from PDE data submitted by drug plans to Medicare by June 30, 2020 with dates of service from January 1, 2019-December 31, 2019. Only final action PDE claims are used to calculate this measure. PDE claims are limited to members who received at least two prescriptions on unique dates of service for statin medication. PDE adjustments made post-reconciliation were not reflected in this measure. Additional data sources include the Common Medicare Environment (CME), the Medicare Enrollment Database (EDB), the Common Working File (CWF), and the Risk Adjustment Processing System (RAPS). • CME is used for enrollment information. • EDB is used for hospice enrollment and ESRD status (dialysis start and end dates within the measurement period). • CWF is used to identify exclusion diagnoses based on ICD-10-CM codes, inpatient and skilled nursing facility (SNF) stays for PDPs and MA-PDs (if available). • RAPS is used for diagnosis information, RxHCC - Dialysis Status (most recent available Payment Year)
Measurement period
01/01/2019 – 12/31/2019
Better when
Higher
Weight
3 (Intermediate Outcome Measure)
Star assignment
Clustering
Case-mix adjusted
—
In improvement measure
Yes
Used in CAI
Yes
Exclusions
ShowContracts with 30 or fewer enrolled member-years (in the denominator). The following beneficiaries are also excluded from the denominator if at any time during the measurement period: • Hospice enrollment • ESRD diagnosis or dialysis coverage dates
Notes
Part D drugs do not include drugs or classes of drugs, or their medical uses, which may be excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, except for smoking cessation agents. As such, these drugs, which may be included in the PQA medication or NDC lists, are excluded from CMS analyses. Also, the member- years of enrollment adjustment is made by CMS to account for partial enrollment within the benefit year. Enrollment is measured at the episode level, and inclusion in the measure is determined separately for each episode – i.e., to be included for a given episode, the beneficiary must meet the initial inclusion criteria for the measure during that episode. The measure is weighted based on the total number of member-years for each enrollment episode in which the beneficiary meets the measure criteria. For instance, if a beneficiary is enrolled for a three-month episode, disenrolled for a six-month episode, reenrolled for a three-month episode, and meets the measure criteria during each enrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + 3/12 = 6/12). The PDC calculation is adjusted for overlapping prescriptions for the same drug which is defined by active ingredient at the generic name level using the NDC list maintained by PQA. The calculation also adjusts for Part D beneficiaries’ stays in inpatient (IP) settings, and stays in skilled nursing facilities (SNFs). The discharge date is included as an adjustment day for IP/SNF stays. Please see Attachment K: Medication Adherence Measure Calculations for more information about these calculation adjustments. When available, beneficiary death date from the CME is the end date of a beneficiary’s measurement period.
Disaster policy
Higher measure star (2020-2021) for contracts with 25% or more enrolled affected by 2019 disasters.

From the 2021 Star Ratings Technical Notes (CMS).

Cut points over time

Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.

How the 2028 cut points are projected

Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.

StarsOrg type2027Projected 2028Move
2★MA-PD8487+3
3★MA-PD8889+1
4★MA-PD9091+1
5★MA-PD9394+1
2★PDP8687+1
3★PDP8889+1
4★PDP9091+1
5★PDP93930

2021 star distribution

Not rated: Plan too new to be measured (186); No data available (39); Not enough data available (33); Plan not required to report measure (9)

Cut point bands

Star yearOrg type1★2★3★4★5★
2027MA-PD< 84 %>= 84 % to < 88 %>= 88 % to < 90 %>= 90 % to < 93 %>= 93 %
2027PDP< 86 %>= 86 % to < 88 %>= 88 % to < 90 %>= 90 % to < 93 %>= 93 %
2026MA-PD< 84 %>= 84 % to < 88 %>= 88 % to < 90 %>= 90 % to < 93 %>= 93 %
2026PDP< 87 %>= 87 % to < 89 %>= 89 % to < 90 %>= 90 % to < 92 %>= 92 %
2025MA-PD< 80 %>= 80 % to < 85 %>= 85 % to < 89 %>= 89 % to < 93 %>= 93 %
2025PDP< 86 %>= 86 % to < 88 %>= 88 % to < 89 %>= 89 % to < 92 %>= 92 %
2024MA-PD< 82 %>= 82 % to < 86 %>= 86 % to < 88 %>= 88 % to < 91 %>= 91 %
2024PDP< 84 %>= 84 % to < 87 %>= 87 % to < 89 %>= 89 % to < 93 %>= 93 %
2023MA-PD< 81 %>= 81 % to < 85 %>= 85 % to < 88 %>= 88 % to < 92 %>= 92 %
2023PDP< 84 %>= 84 % to < 87 %>= 87 % to < 88 %>= 88 % to < 90 %>= 90 %
2022MA-PD< 78 %>= 78 % to < 83 %>= 83 % to < 87 %>= 87 % to < 91 %>= 91 %
2022PDP< 82 %>= 82 % to < 86 %>= 86 % to < 88 %>= 88 % to < 90 %>= 90 %
2021MA-PD< 75 %>= 75 % to < 83 %>= 83 % to < 86 %>= 86 % to < 88 %>= 88 %
2021PDP< 78 %>= 78 % to < 81 %>= 81 % to < 86 %>= 86 % to < 88 %>= 88 %
2020MA-PD< 72%? 72% to < 80%? 80% to < 84%? 84% to < 87%? 87%
2020PDP< 79%? 79% to < 83%? 83% to < 86%? 86% to < 88%? 88%
2019MA-PD< 73%? 73% to < 77%? 77% to < 83%? 83% to < 87%? 87%
2019PDP< 80%? 80% to < 82%? 82% to < 84%? 84% to < 88%? 88%
2018MA-PD< 66%? 66% to < 76%? 76% to < 80%? 80% to < 85%? 85%
2018PDP< 73%? 73% to < 79%? 79% to < 82%? 82% to < 86%? 86%
2017MA-PD< 66%? 66% to < 73%? 73% to < 77%? 77% to < 82%? 82%
2017PDP< 70%? 70% to < 74%? 74% to < 80%? 80% to < 84%? 84%
2016MA-PD< 50%? 50% to < 61%? 61% to < 73%? 73% to < 79%? 79%
2016PDP< 68%? 68% to < 73%? 73% to < 78%? 78% to < 83%? 83%
2015MA-PD< 59%? 59% to < 68%? 68% to < 76%? 76% to < 83%? 83%
2015PDP< 62%? 62% to < 69%? 69% to < 75%? 75% to < 78%? 78%

Lowest-scoring contracts, 2021

ContractParentMembersScoreStarsΔShortfall to 4★Pctile
H9403 Clear Spring HealthGroup 1001—6110250%
S2874 HumanaHumana Inc.—6510210%
H2029 HumanaHumana Inc.06610200%
H7165 Blue Cross Blue Shield of South CarolinaBlueCross BlueShield of South Carolina (BCBSSC)—681—180%
H4140 Doctors HealthCare Plans, Inc.DOCTORS HEALTHCARE PLANS, INC.27,878691—171%
H7522 Medicare y Mucho Mas (MMM)Elevance Health, Inc.06910171%
H4005 Triple-S AdvantageGuidewell Mutual Holding Corporation6,4907010161%
H9590 Longevity HealthLongevity Health Founders, LLC976701—161%
H5577 MCS ClassicareMHH Healthcare, L.P.361,0207010161%
H2793 Imperial Insurance Companies, IncImperial Health Plan of California—711—152%
H4007 HumanaHumana Inc.—7220142%
H4003 Medicare y Mucho Mas (MMM)Elevance Health, Inc.94,1087220142%
H4490 American Health Advantage of MissouriMitchell Family Office832721−1142%
H6672 Clear Spring HealthGroup 1001—7210142%
S1894 CommunityCare Prescription Drug Plan (PDP)St Francis Health System & St John Health System—782—82%
H9878 Bright HealthBright Health, Inc.—731—133%
H3239 Aetna MedicareCVS Health Corporation53,902731—133%
H5774 Triple S AdvantageGuidewell Mutual Holding Corporation121,3847310133%
H0982 Solis Health PlansAthena Healthcare Holdings, LLC26,276731—133%
H4853 Bright HealthBright Health Group, Inc.—741−1123%
H5422 Anthem Blue Cross and Blue ShieldElevance Health, Inc.14,085741−1123%
H9585 WellSense Health PlanBMC Health System, Inc.—7520114%
H9276 AllwellCentene Corporation—7520114%
H5991 EmblemHealthEmblemHealth, Inc.2,2857520114%
H8854 CareFirst BlueCross BlueShield Advantage DualPrimeCareFirst, Inc.8,5997520114%

History

Star yearCodeNameMeasuredWeightSource
2027D10Medication Adherence for Cholesterol (Statins)01/01/2025 – 12/31/20253Prescription Drug Events
2026D10Medication Adherence for Cholesterol (Statins)01/01/2024 – 12/31/20243Prescription Drug Events
2025D10Medication Adherence for Cholesterol (Statins)01/01/2023 – 12/31/20233Prescription Drug Events
2024D10Medication Adherence for Cholesterol (Statins)01/01/2022 – 12/31/20223Prescription Drug Events
2023D10Medication Adherence for Cholesterol (Statins)01/01/2021 – 12/31/20213Prescription Drug Events
2022D10Medication Adherence for Cholesterol (Statins)01/01/2020 – 12/31/20203Prescription Drug Events
2021D12Medication Adherence for Cholesterol (Statins)01/01/2019 – 12/31/20193Prescription Drug Events
2020D12Medication Adherence for Cholesterol (Statins)01/01/2018 – 12/31/20183Prescription Drug Events
2019D12Medication Adherence for Cholesterol (Statins)01/01/2017 – 12/31/20173Prescription Drug Events
2018D13Medication Adherence for Cholesterol (Statins)01/01/2016 – 12/31/20163Prescription Drug Events
2017D14Medication Adherence for Cholesterol (Statins)01/01/2015 - 12/31/20153Prescription Drug Events
2016D14Medication Adherence for Cholesterol (Statins)01/01/2014 - 12/31/20143Prescription Drug Events
2015D13Medication Adherence for Cholesterol (Statins)01/01/2013 - 12/31/20133Prescription Drug Events